Notably, the prognostic implications of OLFM4 vary by cancer type; for instance, reduced OLFM4 expression correlates with prostate cancer progression [7], whereas elevated expression is associated with poorer outcomes in pancreatic cancer [5]. This evidence concerns the gene OLFM4 and cancer.